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Surveillance and Elimination of 
Bacteriophage Contamination in 
an Industrial Fermentation Process
James A. Zahn and Mathew C. Halter
Abstract
Commercial fermentation processes are often vulnerable to bacteriophage due 
to the lack of genetic diversity and use of high cell density cultures. Bacteriophage 
infections in these fermentations can have adverse impacts on operability of the 
production facility and product quality and prevent recovery of valuable bioprod-
ucts in the downstream process. Prevention strategies have been developed and 
optimized through feedback from bacteriophage diagnostic tests, which inform 
improvements to process design for elimination of entry points, as well as modifica-
tion of the biocatalyst to reduce or eliminate bacteriophage virulence. In this chap-
ter, we provide case studies for successful elimination of bacteriophage virulence 
via host modifications, including bacteriophage binding-site modifications on the 
outer membrane of an Escherichia coli production host, used for commercial manu-
facture of 1,3-propanediol, as well as application of CRISPR-associated protein 9 
(Cas9) for bacteriophage immunity. Finally, we report application of bacteriophage 
diagnostic methods to fully characterize and eliminate bacteriophage entry points 
in a commercial fermentation process.
Keywords: bacteriophage, white biotechnology, industrial fermentation, CRISPR, 
Cas9, phage
1. Introduction
Increasing awareness of our dependence on petroleum, coupled with the 
negative effects of this dependency on oil supply, price volatility, and gas emis-
sions, is the driver behind the growing global market for biorenewable chemicals 
made through white biotechnology processes. In 2011, revenue from biorenewable 
chemicals exceeded $2.4 billion, and revenue continues to grow at a compound 
annual growth rate of 14.8%, with glycerin and lactic acid accounting for 79% of the 
 market share [1]. Growth for biorenewable chemicals that are used as monomers the 
manufacture of bioplastics represents a fast-growing segment of this industry [1].
One example of a biorenewable chemical that has displaced petrochemical 
manufacturing routes is 1,3-propanediol or BioPDO™. This chemical had histori-
cally been manufactured using petroleum-derived ethylene oxide or acrolein [2, 3]. 
In 2006, DuPont Tate & Lyle Bio Products, a joint venture formed between DuPont 
and Tate & Lyle, commercialized an aerobic fermentation process for production 
of 1,3-propanediol (BioPDO™) from glucose derived from yellow dent field corn. 
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A life cycle analysis (LCA) showed that the BioPDO™ manufacturing process con-
sumed 42% less energy and emitted 56% less greenhouse gas emissions than petro-
chemical manufacturing routes. BioPDO™ is included as a raw material in polyester 
manufacture for textiles, carpet (Sorona®), and thermoplastic resins (Sorona®EP). 
Furthermore, BioPDO™ has direct uses in foods, cosmetics, and personal care 
applications through the Zemea® brand, and heat transfer, homopolymer, polyure-
thane, and other industrial applications through the Susterra® brand [3, 4].
In addition to a more favorable life cycle analyses, White Biotechnology pro-
cesses like the BioPDO™ process demonstrate many advantages over petrochemical 
processes, such as the ability of the process to maintain high specificity [5], high 
yield, and ability to maintain lower concentrations of chemical intermediates that 
are generally recognized to form undesirable impurities in the final product [6].
Although many advantages exist for bioprocesses, disadvantages include (a) low 
to moderate productivity rates requiring intensification capital investments related 
to equipment capacity, (b) process susceptibility to bacterial and bacteriophage 
contamination, which has a negative impact on operability factor, (c) generally 
higher variable cost of manufacturing due to high electrical and related energy 
costs, (d) high water use, (e) odors, (f) costs associated with the production and 
filtration of large volumes of gases required for the fermentation process, and 
treatment of waste gases to remove odors, viable cells, and regulated or unregulated 
chemicals, (g) higher separation and refining costs due to the presence of large 
amounts of water, and (h) disposal of large volumes of nonhazardous waste.
In this chapter, we provide a detailed analysis of one of the most challenging 
issues for white biotechnology processes, which is the prevention of lytic bacte-
riophage events in commercial fermentors. Bacteriophages can cause rapid lytic 
infections of the highly clonal bacterial populations that are used in white biotech-
nology processes. Lytic infections of bacteria by bacteriophage reduce or abolish 
product productivity, and reduce the efficiency of cell recovery methods, which 
causes reduced product quality or a complete loss of the product. Batches affected 
by lytic bacteriophage infections cause a loss in production capacity or asset utiliza-
tion, and financial losses to a business [7]. Lytic events in industrial fermentation 
may necessitate temporary shutdown of the facility for cleaning and elimination of 
bacteriophage, or even prolonged shutdown periods for cleaning and modification 
of aseptic barriers in the facility. In addition to surveillance and elimination best 
practices, this chapter outlines facility design considerations that are important in 
the prevention of bacteriophage in a biomanufacturing facility.
2.  Prevalence of bacteriophage contamination in industrial fermentation 
processes
With the steady increase in the use of prokaryotic biocatalysts over the course 
of the last several decades for protein, small molecule, and chemical produc-
tion, a focus has been placed on maintaining a bacteriophage-free environment 
in the manufacturing facility. The prevalence of bacteriophage in commercial 
fermentation processes varies considerably within the industry. For example, there 
have been no reported bacteriophage-related losses in certain industrial process, 
including: (a) syngas fermentations utilizing Clostridium ljungdahlii, Clostridium 
autoethanogenum, and Clostridium coskatii; (b) the commercial process for produc-
tion of Spinosad and Spinetoram using Saccharopolyspora spinosa; and the com-
mercial process for (c) production of xanthan gum by Xanthomonas campestris. In 
contrast, moderate to severe fermentative losses have been observed for certain 
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bacterial-mediated processes, including the acetone-butanol-ethanol process that 
uses Clostridium acetobutylicum, Clostridium beijerinckii, or Clostridium sp. [8]; the 
Escherichia coli-mediated NutraSweet® process [9]; the E. coli-mediated BioPDO™ 
process [10]; the vinegar fermentation processes that uses Acetobacter europaeus, or 
Acetobacter sp. [11]; and food processes that utilize various bacteria [12, 13].
Although no single factor appears to link processes that are susceptible to 
bacteriophage-induced fermentative losses, some common themes exist:
a. Tanji et al. [14] proposed that “the most likely source of phage contamina-
tion in the E. coli culturing process is human, since E. coli is one of the main 
inhabitants of the gastrointestinal tracts of warm-blooded animals.” Infection 
of microflora present in fermentation plant personnel may serve as a reservoir 
to maintain bacteriophage in the plant environment for extended periods of 
time [15]. Production hosts that are incapable of human colonization or that 
exhibit distinct phylogenetic differences to the natural human microflora may 
be advantaged over E. coli production hosts for these processes.
b. Certain processes using E. coli have a distinct disadvantage that aseptic design 
and operation principles are unknowingly sacrificed by continuous improve-
ment programs, which focus on minimizing process cycle time, or related cost 
reductions. Processes that produce end products that are inhibitory to foreign 
bacterial growth are especially vulnerable since a false sense of security is 
provided by the fact that the E. coli production hosts exhibit improved com-
petitiveness over most other microorganisms. Under these conditions, foreign 
growth, which may harbor bacteriophage, can go undetected or unreported. 
Process cycle time improvements typically target a reduction in maintenance 
tasks supporting sterile barriers, or a reduction in time allotted for sterilization 
and clean-in-place (CIP) procedures to clean piping, valves, and vessels. These 
efforts can negatively impact bacteriophage elimination programs.
c. Xanthomonas campestris has a number of established bacteriophages that 
have been registered as biocontrol agents to minimize its impact as a plant 
pathogen [16]. Therefore, the absence of bacteriophage-induced losses for the 
 commercial xanthan gum process is aligned with the absence of an appropriate 
reservoir in the manufacturing facility that ecologically supports X. campestris 
growth.
d. Microorganisms with doubling times greater than 2–3 hours, which includes 
Saccharopolyspora spinosa, Clostridium ljungdahlii, and Clostridium autoethano-
genum, often exhibit effective DNA restriction-modification systems that serve 
to destroy foreign DNA that enters the cell. These microorganisms are typically 
referred to as recalcitrant to recombinant DNA technology, as measured by 
low or unmeasurable transformation efficiency [17]. More recently, a number 
of widespread bacteriophage immunity systems have been described, some of 
which contain elements that act similarly to restriction-modification systems, to 
modify or destroy both foreign (i.e., non-native plasmid or cosmid-associated 
DNA) and bacteriophage-associated DNA [18, 19]. Interestingly, the E. coli 
production host used for the BioPDO™ processes was found to lack a functional 
bacteriophage exclusion operon (BREX [18]), as well as a functional CRISPR-
Cas restriction-modification system [7, 20]. Highly optimized strains utilized 
in commercial manufacturing process often contain intended and unintended 
modifications to the host chromosome that contribute to improved rate,  
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titer, and yield. Although the BioPDO™ production host contains nearly a 
complete E. coli K12 CRISPR-Cas operon (Figure 1), upstream regulatory 
modifications, which were correlated with improved product production rate 
resulted in the loss of function for this operon. Vale et al. [19] found that “Cas 
protein expression is particularly costly, as Cas-deficient mutants achieved 
higher competitive abilities than the wild-type strain with functional Cas 
proteins.” Smaller spacer libraries of approximately four spacers or less were 
not associated with fitness costs, suggesting that the genetically engineered 
spacer library approach of Halter and Zahn may serve to minimize energy and 
ATP burden on the cell, as indicated by the minimal impact of recombinant 
seven-spacer system on 1,3-propanediol biosynthesis [7].
2.1  Isolation and identification of bacteriophage DNA from lytic production 
samples in the BioPDO™ process
Lytic bacteriophage infection with the BioPDO™ process is characterized by 
sudden cellular lysis, which coincides with a sudden and rapid increase in dissolved 
oxygen (to 100% dissolved oxygen), a complete loss of oxygen uptake rate, and a 
complete loss of carbon dioxide evolution rate during the fed-batch fermentation. 
Optical density (OD) of the fermentation decreases rapidly from an OD550 nm at 
approximately 11 hours of 42 ± 2 absorbance units to less than 1.4 ± 0.5 in a period 
of 30–40 minutes. Viable cell counts for the process show that a nearly complete 
10-log reduction occurs within this time period. As in-house molecular techniques 
for bacteriophage detection were not initially developed at the time of facility 
start-up, these early events were poorly characterized. However, procedures existed 
to sample and preserve fermentor samples in segregated freezers to support future 
investigative efforts. Fermentor samples that were collected consisted of a crude 
mixture of cleared (lysed) E. coli cells, nucleic acids, proteins, and cell membrane 
components. These samples were subsequently determined to contain bacterio-
phage particles, which were directly observed by transmission electron microscopy 
(Figure 2).
2.1.1 DNA isolation methodology
Samples were syringe-filtered through a 0.2-μm filter to separate the larger 
cell debris, and bacteriophage particles were precipitated and concentrated for 
transmission electron microscopy (Figure 2). To improve DNA sequencing efforts, 
Figure 1. 
Alignment of the E. coli K12 CRISPR operon (upper panel) with the native nonfunctional CRISPR-Cas operon 
in the BioPDO™ E. coli production host (lower panel).
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bacteriophage nucleic acids were separated from lysed E. coli DNA. The bacterio-
phage DNA is protected by the proteinaceous capsid head, allowing for DNAse digest 
of exogenous E. coli DNA. Filtered samples were incubated with DNAse I according 
to the manufacturers recommended protocol overnight, ensuring complete diges-
tion of all DNA present that could interfere with bacteriophage DNA sequencing. 
After complete digestion, the DNAse was deactivated by heat denaturation. The 
next step was the removal of the bacteriophage capsid protecting the DNA. This 
was performed by treatment with proteinase K according to the manufacturer’s 
protocol for 3 hours. The proteinase K treatment removes the capsid protein shell, 
allowing the bacteriophage DNA to enter solution. Now that the bacterial DNA was 
fully degraded and the bacteriophage DNA removed from the particle capsid, the 
final remaining steps were simply precipitating the remaining protein from solution, 
separation from the aqueous phase by centrifugation, and precipitation of nucleic 
acids. Protein precipitation was performed by addition of 2 M potassium hydroxide. 
Immediate flocculent formation was evident, but the samples were stored on ice for 
a short period to encourage further protein precipitation. Chilled samples were cen-
trifuged in a tabletop centrifuge at 13,000 × g for 10 minutes to separate the protein 
flocculent from the nucleic acid-containing supernatant. Upon separation, nucleic 
acids were precipitated through a 50% isopropyl alcohol wash. Samples were again 
stored on ice to allow precipitation to progress more efficiently, followed by centrifu-
gation at 13,000 × g for 5 minutes. The visible, cloudy DNA pellet was resuspended 
in ddH2O and quantified for sequencing.
2.1.2 Bacteriophage typing
The isolated DNA was sent for 454 pyrosequencing, which revealed an approxi-
mately 46,000 base pair circular genome. The genomic characterization of the 
plasmid was described previously [7]. Sequence analysis of genomes isolated 
from lytic batches ranging back to the manufacturing facility start-up in 2006 
revealed an interesting fact that every lytic bacteriophage event was caused by the 
same bacteriophage. This bacteriophage shared sequence homology with a T1-like 
bacteriophage, referred to as RTP bacteriophage [21], but sequence homology of tail 
fibers and other open reading frames in the genome indicated it was a new repre-
sentative of this group [7]. To reflect the source of the novel bacteriophage, it was 
named “DTL-phage,” for the location of its discovery at the DuPont Tate & Lyle Bio 
Products fermentation manufacturing site. It is noteworthy that with the signifi-
cant diversity of coliphages in nature, only one specific type of bacteriophage was 
Figure 2. 
Transmission electron micrograph of bacteriophage DTL.
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detected over a period of 12 years. The prevalence of this particular bacteriophage 
at this facility was likely enhanced by the lack of significant changes in bacterio-
phage resistance in the E. coli host strain, and the massive amount of bacteriophage 
particles that was released from the site’s five—600,000-L production fermentors. 
With a burst size of approximately 300 new phage particles with each cell lysis, 
infected fermentors were estimated to release approximately 2 × 1015 viral particles 
per affected fermentor, which were then distributed to vent and broth deactivation 
systems where these phage particles were presumed to be deactivated. Subsequent 
viral load studies showed that large amount (40–65%) of the bacteriophage pres-
ent in liquid and respiratory off-gas analysis streams remained active. Although a 
majority of flow in these systems was contained, broth from in-process fermentor 
sampling efforts, and a majority of excess flow from off-gas analysis streams for 
respiratory gas analysis was not contained, and contributed to bacteriophage-
containing aerosols, and dried particulate matter, which was disseminated in the 
production facility.
While we have shown that bacteriophage DTL is highly selective for E. coli 
(Figure 3), it is capable of lysing several different E. coli Group A representatives 
and related subspecies (Figure 4), suggesting that bacteriophage particles could 
infect related E. coli subspecies present in the local manufacturing environment, 
since these representatives are common human and animal inhabitants [14].
Since the bacteriophage plaque assays provide slow (34–48 hours) feedback for 
the presence of bacteriophage contamination in process samples, development of 
a rapid diagnostic test was considered a critical path for effectively mitigating fer-
mentative losses in the facility. To this end, polymerase chain reaction (PCR) assays 
were developed to detect DTL-phage nucleic acids in fermentation broth (Table 1). 
Primer sets were designed based on the genome sequence ([22]; Genbank accession 
number MG050172), and endpoint reactions performed on both lysed and nonlysed 
fermentation samples were run on 1% agarose gel, providing a binary visual confir-
mation of the presence or absence of DTL-phage genomic DNA (Figure 5).
Figure 3. 
Plaque assays using DTL-phage on phylogenetically diverse bacteria. From the top panel—left to right: 
Escherichia coli FM5, E. coli ATCC 8739, Enterobacter aerogenes ATCC 13048: from the lower panel—left to 
right, Klebsiella pneumoniae ATCC 15574, Pseudomonas aeruginosa ATCC 9027, and Pseudomonas fluorescens 
ATCC 13525. Background spotting, which is most notable with P. aeruginosa is due to nutrient carry over in the 
phage preparation.
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After optimization of the assay, early PCR screening of every fermenter was 
implemented in the manufacturing facility for transfer of seed fermentors. It was 
soon clear that endpoint PCR, followed by gel-electrophoresis was still too slow 
to effectively meet the 2-hour transfer window in the manufacturing process, 
and secondly, the technical tasks and decisions were too complex to effectively 
implement for the nontechnical manufacturing facility workforce. Real-time 
quantitative PCR is an assay that provides a more rapid result (<1 hour), and 
also produces a threshold cycle (Ct) count that can be used as a straightforward 
quality control parameter to set a simple quantitative threshold for amplicon 
copy numbers. The use of real-time quantitative PCR to track fermenter con-
tamination provides a more rapid screening procedure and reduces the time from 
fermentor sampling to a formation of a transfer decision by slightly over 1 hour. 
Primer sets were optimized to amplify targets within the bacteriophage DTL 
genome with above 95% efficiency, and premade reaction cocktails were also 
developed to minimize low-volume pipetting steps needed to be performed by 
nontechnical staff. This procedure had the following steps: (a) A seed fermenter 
sample would be collected by the fermentation technician and transferred into 
Figure 4. 
Susceptibility of Escherichia coli group A representatives and related E. coli subspecies to DTL-phage. 
Susceptible = BL21, DH5α, B178, W2244, FM5, and W1485. Nonsusceptible = BW25113 and K802.
Primer Sequence
DTL-phage 43 qRT F GAAGAGGTGTTTAATTTCGCCG
DTL-phage 43 qRT R GCCAAACCCGTTAATGTGAAC
DTL-phage 40 qRT F AGAGGTAGTGGTAGGTTCCG
DTL-phage 40 qRT R TCAAGAATCGCAGAGTAACCG
DTL-phage 19 qRT F GCACGCTGGTTAATGGAATG
DTL-phage 19 qRT R TTCTTGATGGAGATTGTCGGG
DTL-phage 6 qRT F GGCGTAAAACAGTAATTCAGGTC
DTL-phage 6 qRT R TTCACACCATCACTACCATCAG
DTL-phage 66 qRT F GCAGTAAGCCAGAGATTAGCG
DTL-phage 66 qRT R CTATCCAGTGACCCAACCTTG
Table 1. 
DTL-phage primer sets for PCR diagnostic testing.
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a class 2 biological safety cabinet. (b) The sample would be filtered through a 
0.2-μm sterile syringe filter to remove intact cells, and then diluted 1:10 in sterile 
water. This dilution was performed to dilute inhibitory substances  present in 
the fermentation media, allowing for elimination of the DNA extraction step. 
(c) Load the processed sample with positive and negative controls into the 
quantitative PCR instrument, and initiate the analysis. This qPCR assay was 
the cornerstone in a strategy to screen seed fermentors prior to transfer to the 
production fermentor as a safeguard to limit bacteriophage-infected seeds from 
contaminating production fermentors. This new procedure included control 
charting intensities for Ct trends, which aided in the tracking of bacteriophage 
contamination levels (Figure 6), which increased the operability factor for the 
Figure 5. 
DTL-phage amplicons generated from PCR (DTL-phage 40 set, Table 1) and separated by 1% agarose gel 
electrophoresis. Lane 2 is a positive control of purified DTL-phage DNA, lane 3 is a seed fermenter sample 
containing 2 × 104 particles of DTL-phage per mL, and lane 4 is a sterile water negative control. Lane 1: 
Invitrogen E-Gel 1 Kb Plus Express DNA Ladder (part #10488091) 100–5000 bp.
Figure 6. 
Quantitative PCR (qPCR) amplification curves of seed media screened for DTL-phage. Blue colored curves 
represent a positive control for presence of DTL-phage (equivalent to 180 plaque forming units per milliliter), 
green curves represent a negative control, and red curves represent the seed media being screened. The left panel 
shows a negative result for the seed fermentation sample with no detectable DTL-phage, and the right panel 
shows a positive response for a seed fermentation sample that contained an internal addition of 80 plaque 
forming units per milliliter.
9Surveillance and Elimination of Bacteriophage Contamination in an Industrial Fermentation…
DOI: http://dx.doi.org/10.5772/intechopen.81151
fermentation process by ensuring that only bacteriophage-free seed material was 
transferred into production fermentors.
2.2 Efforts to produce a bacteriophage-resistant production strain
There is a clear incentive for businesses that utilize fermentation-based manu-
facturing technologies to invest in the development of production strains that are 
resistant to potential bacteriophage threats. There are at least four target areas 
that have been described in literature for enhancing bacteriophage resistance in 
prokaryotic organisms that are sensitive to lytic bacteriophage infections [23]: 
(a) prevention of phage adsorption, (b) preventing phage entry, (c) cutting bacte-
riophage nucleic acids, and (d) abortive infection systems. The following analysis 
will summarize efforts in two of the four areas and prevention of phage adsorption 
and cutting phage nucleic acids with a heterologous CRISPR-Cas system.
Classical strain improvement programs for the generation of bacteriophage 
resistance often start with acquiring genotypic diversity in a host population 
through spontaneous or induced mutation, followed by challenge and selection of 
survivors to bacteriophage infection. Several studies utilizing this strategy have 
reported resistance through single nucleotide polymorphisms (SNPs) or inser-
tional mutagenesis, which often alters the structure of bacteriophage binding 
sites on the cell surface. Additionally, significant deletions of chromosomal DNA 
have been described that involve structural changes of one or more cell surface 
 biomolecules [14, 24–26].
The initial step in the bacteriophage virulence cycle is the adsorption of the 
bacteriophage particle to the outer surface of the bacterial cell [23]. Once bound, 
the bacteriophage infects the cell by transferring genetic material into the cell, 
where it then utilizes host cellular translation systems to generate additional bac-
teriophage particles. This binding of the bacteriophage to the outer membrane is 
typically mediated by a highly specific receptor on the outside of the cell, is typi-
cally a membrane protein, a specific class of lipid, or a carbohydrate moiety, and 
is extremely specific to a bacteriophage and its host. Common genetic techniques 
can, therefore, be used to target these binding sites to reduce binding affinity or 
eliminate the site [24, 26].
Over several years, classical strain improvement programs for the BioPDO™ 
process have generated and screened strains that were selected through chal-
lenge for resistance to DTL-phage [7]. These screens included strains that 
demonstrated a 3–5-log improvement in the reduced sensitivity as measured 
by the standard bacteriophage plaque assay (Figure 7). In all cases, bacterio-
phage resistance was associated with a 63–96% reduction in 1,3-propanediol 
production titer. Further analysis showed that these strains had a lower solvent 
tolerance, which indicated that the bacteriophage resistance mechanism(s) were 
presumably linked to changes in cellular ultrastructure. Genomic sequencing 
efforts confirmed that SNPs occurred in a series of genes involved in synthesis 
and glycosylation of lipopolysaccharide, including glycosylation with heptose 
residues [27]. Heptose residues appear to be essential for high-affinity binding 
of DTL-phage to the E. coli cell [28].
The second strategy, cutting bacteriophage nucleic acids is a rapidly evolving 
field that has been heavily influenced by recent discoveries in bacterial-acquired 
immunity [12]. Clustered regularly interspaced short palindromic repeats (CRISPR) 
are a molecular system by which prokaryotes obtain acquired resistance to bacterio-
phages. The CRISPR operon is widely distributed in prokaryotes and represents the 
most abundant form of innate immunity in these organisms [29]. Upon injection of 
the genetic material, the cell recognizes foreign DNA, and the first gene involved 
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in the CRISPR pathway creates an approximately 20–25 base pair cut (this varies 
between species and CRISPR subtypes). This snippet of DNA is then integrated 
into a library of recognized bacteriophage genetic elements, flanked on each side 
by a palindromic repeat. This genetic element can then be transcribed, producing 
a single-stranded transcript that is homologous to the DNA of the intruding bacte-
riophage. The palindromic repeats flanking the element serve to bind the short frag-
ment of transcript to a nuclease, which is then guided by the homologous element to 
potential binding sites on the intruding segment of DNA, where a single cut is made 
rendering it nonfunctional.
Since it was established earlier that the BioPDO™ E. coli production host did not 
carry a functional CRISPR operon in its genome, and the specific binding site of the 
DTL-phage was originally unknown, work was initiated with CRISPR to generate 
a spacer library specific to DTL-phage infection. The well-characterized CRISPR 
cassette of Streptococcus thermophilus was amplified, and its 12 bacteriophage spacers 
(remnants of previously acquired resistance in this species) were replaced with seven 
spacers that were homologous to different regions of the DTL-phage genome. These 
seven spacers were specifically chosen to deliver CRISPR-nuclease-delivered cuts 
in the middle of important open reading frames within the bacteriophage genome, 
thereby ensuring overwhelming and targeted knockout of its genetic functionality.
Upon incorporation of this tailored cassette to the BioPDO™ E. coli production 
strain, plaque assays and phage challenges indicated the organism had obtained full 
resistance to this bacteriophage, as indicated by the lack of plaques formed in experi-
ments using phage titers as high as 106 phage particles per milliliter. The utilization 
of multiple homologous spacers was an important aspect of this project to reduce the 
potential for resistance. Because CRISPR resistance depends on homologous binding 
of spacers bound to the CRISPR nuclease to the intruding phage DNA, a single SNP 
acquired within the homologous stretch of DNA in the phage genome could disrupt 
the DNA-nuclease interaction, rendering that spacer no longer active. The use of seven 
 targeted spacers minimizes the potential for resistance, and no significant energy or ATP 
burden related to the lack of fitness hypothesis, proposed by Vale et al., was observed 
[19]. Although Vale et al., proposed a threshold number of four spacers as the limit 
regarding negative impacts on cell fitness, the slight increase to a seven-spacer library 
appeared to have no negative consequences on 1,3-propanediol synthesis rate [7].
Figure 7. 
Bacteriophage plaque assay plate showing the presence of E. coli colonies growing in the zone of clearing that 
are resistant to DTL-phage challenge.
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2.3  Reservoirs and process entry points for bacteriophage in a manufacturing 
setting
Host resistance to bacteriophage infection is only a partial solution to the 
prevention of bacteriophage in fermentation processes. This approach must be 
balanced with effective facility sanitation procedures, active bacteriophage surveil-
lance programs that are coupled with reservoir elimination efforts, and finally, the 
validation, maintenance, and monitoring of aseptic barriers utilized in the process 
for bacteriophage exclusion.
As mentioned previously, bacteriophage-infected production fermentors 
for the BioPDO™ process were estimated to release approximately 2 × 1015 viral 
particles per affected fermentor based on a 300-burst size model. Bacteriophage-
contaminated air and liquid in fermentors was transferred to vent and broth 
deactivation systems where the viral particles were presumed to be deactivated. 
Earlier pilot plant studies of microbial and biological materials deactivated by a 
high-temperature short-time sterilizer (HTST) did not consider bacteriophage 
inactivation because (a) bacteriophage was considered an addressable nuisance in 
the operation of the facility, (b) bacteriophage libraries specific to the BioPDO™ 
production microorganism had not been assembled, and (c) risks to a commercial 
process remained largely speculative. Furthermore, the closest-related bacterio-
phage, RTP-phage had not been isolated and described until after the plant start-up 
in 2006. Subsequent heat-inactivation studies on phage-contaminated batches 
after facility start-up were successful in showing that bacteriophage particles were 
not completely deactivated in the HTST broth deactivation system, mainly due to 
resistance to heat inactivation [30, 31].
Other weaknesses in containment systems were gas and liquid sampling  systems, 
which were commonly used in the fermentation industry for respiratory gas 
analysis and control through feedback loops, and in-process analytical for measur-
ing broth parameters associated with growth and product production, respectively. 
Once free of containment systems, the bacteriophage particles were unintention-
ally disseminated by human activity and other environmental mechanisms. This 
disseminated material served to challenge sterile barriers that were in place for air 
filtration, filters used for sterile filtration of liquids used in the process, and cross 
contamination of microbiology process laboratories, which impacted the seed train, 
and laboratory diagnostic tests.
The ecological aspects of DTL bacteriophage are poorly characterized due to the 
lack of historical environmental samples from the fermentation facility during the 
period of the initial infection. We are in agreement with the proposal of Tanji et al. 
[14] that the most likely source of phage contamination for an E. coli culturing 
process is human, and the initial source of DTL-phage in the BioPDO™ facility, 
was most likely also human. The fact that DTL phage is now prevalent in the plant 
environment is thought to be mainly a result of a series of lytic events in produc-
tion fermentors that established localized concentrations of the bacteriophage in 
reservoirs that are inhabited by natural populations of E. coli, or closely related 
microorganisms that are susceptible to this bacteriophage.
One of the most significant failure points in the commercial fermentation facil-
ity process for bacteriophage entry was through sterile filtration barriers. The small 
size of DTL-phage (capsid diameter = 0.075 μm) supports passage of the virus 
through liquid-service filtration systems (0.2–0.45 μm cutoff size), and conditional 
passage through gas-phase filtration systems (0.2 μm cutoff size) when entrained 
liquid is present. Aerial transfer of bacteriophage particles is well-established as a 
route for contamination of industrial fermentation processes [29, 30]; therefore, 
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air filtration systems play a large role in protecting the fermentation process from 
airborne bacteriophage particles.
Our empirical studies on the Donaldson sterile air filter, model P-SRF N 30/30 
(0.2 μm absolute, expanded PTFE filter membrane) indicated that the filter was 
100% effective in rejection of DTL-phage particles if the filter remained above 
the system pressure dew point temperature of 102.5°F (Figure 8). Since the design 
temperature of air present in the header was 122, the 102.5°F pressure dew point 
was considered to have sufficient safety factor to prevent formation of condensate. 
Wetting of the filter was correlated strongly with lytic infections by DTL-phage 
[7]. Wetting of the sterile filter due to entrained water in the process air header 
was infrequently observed when: (a) low ambient temperatures cooled areas of 
the process air header that were not adequately protected with heat tape and/or 
insulation (Figure 9), (b) cooling tower water or chilled water from the intercooler 
and/or aftercooler heat exchangers on the air compressor leaked into the air stream 
and traveled through the air header to prefilters and sterile filters, (c) low-point 
zones in the process header not adequately drained with autopurging condensate 
traps, and (d) high-temperature excursions of the chilled water system, which was 
used to condense water in the compressed air product stream. A critical factor for 
surveillance and prevention of bacteriophage contamination was the integration of 
dew point sensors at upstream locations from the sterile filter, and more frequent 
sterilizations of the filters in the sterile filter housing. Since sterile filters have a 
limitation of approximately 170 steam cycles, more frequent sterilization served to 
increase the number of filter replacements and overall process costs.
Bubble column bioreactors used in aerobic fermentation processes require 
large volumes of air to meet the oxygen uptake requirements for E. coli cells in the 
fermentation, as well as a means for mixing to drive heat transfer, gas solubility, 
CO2 ventilation or removal, and mixing of substrates, and other feeds. Due to the 
expense of water vapor removal in very large volumes of air, many fermentation 
systems utilize ANSI/ISA-7.0.01-1996 air quality class 6 or lower specifications, 
which establish a dew point of 50°F at atmosphere pressure. This type of air com-
pressor system, which contains chilled fluid after-coolers, passes the compressed 
air through a cooled heat exchanger, causing water vapor to condense out of the air 
stream, and typically produces air with a dew point not lower than 41°F (5°C). The 
pressure dew point refers to the dew point temperature of a gas under pressure, 
which in this case is increased to a value of 102.5°F at a pressure of approximately 
84.7 psia (Figure 9). The main issues with this system are (a) the potential for 
Figure 8. 
Sterile process of destructive disassembly a Donaldson sterile air filter, model P-SRF N 30/30 (0.2 μm absolute, 
expanded PTFE filter membrane) for bacteriophage diagnostic testing. Note the dark water staining on 
protective prefilter barrier layer on the filter.
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heat exchanger leakage into the air stream and (b) temperature excursions of the 
cooling fluid (chilled water), due to its use in other areas of the manufacturing 
facility. Temperature excursions for chilled water were found to reduce the ability 
of the after-cooler to remove water vapor in air supplied to the fermentors, which 
increased the potential for condensate to form in the process air header. This con-
densate was found to cause passage of bacteriophage particles through the sterile, 
0.2-μm air filter.
Deviations from aseptic design principles are nearly always a root cause for 
introduction of foreign bacterial growth and bacteriophage into axenic fermenta-
tion systems. A deviation in these principles occurred as part of the risk mitigation 
effort to prevent condensate formation in the process air header. As part of this 
project, sterile air bypass lines were installed on the air header line to eliminate 
zero air flow conditions that occurred during the sterilization cycle for fermentors. 
During fermentor sterilization, sterile air flow was stopped, and a 45 psig steam 
feed line between the sterile filter housing and fermentor was opened. During the 
90-minute sterilization cycle, the temperature of the air header was found to drop 
well below the pressure dew point, especially during cold weather months, which 
introduced condensate upstream of the sterile air filters. Introduction of a process 
steam line upstream of the sterile filter housing, as is done more commonly in the 
industry, was not considered a best practice because the sterile air filter would 
remain wetted for a short period after the steam sterilization process was com-
pleted, and nonsterile air flow was reinitiated as a feed stream to the filter housing. 
The wetted filter was believed to promote passage of bacteriophage particles into 
the fermentor. One solution, practiced at a separate facility, was to have a secondary 
low-flow sterile air header upstream of the main sterile filter housing that provided 
sterile dry air to the housing after the steam sterilization to dry the wet sterile fil-
ters. As these former solutions required significant down time to perform repiping, 
two other solutions were prioritized: (1) ensure that heat tracing and insulation of 
the air header was sufficient to maintain temperature above the pressure dew point 
and (2) prevent the low or no-air-flow condition by adding a small diameter purge 
line directly after the sterile air filter housing to provide constant flow in the air 
header. Due to the potential for ammonia gas in the bypass air stream, piping effort 
focused on connection of this line to the fermentor exhaust header, which contained 
an ammonia scrubber system. The new piping system did not contain proper 
aseptic barriers and steam-purged interlocks, which then permitted backflow of 
Figure 9. 
Diagram of the process air system that provided a sterile-filtered air to a production fermentor.
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contaminated waste gas into the fermentor air header (poststerile filter) under 
infrequent vent header over-pressure events.
One of the more surprising discoveries in this work was the level of bacterio-
phage contamination (up to 7 × 103 plaque forming units per square centimeter) in 
the process air header, as well as the surface of sterile air filters between sterilization 
cycles. This result indicated that the extremely short, but elevated air temperature 
of 260°F between the air compressor and after-cooler was insufficient in deactivat-
ing DTL-phage (Figure 9). Based on this finding, air header sanitation procedures 
were developed to infrequently steam sterilize the air header for the location 
between the preair filter housing and the air compressors. While this practice 
reduced phage burden in the air header, it could not be operated in a continuous 
mode, and therefore, the sterile air filters served as the only barrier to bacteriophage 
entry. Additional design improvements related to a secondary barrier for airborne 
phage entry include: (a) a heat-sterilization system on the product side of the air 
compressor to elevate the temperature to 300°F, and increase temperature hold time 
by 10-fold to 1 second, and (b) filtration/precipitation systems for pretreatment of 
supply air to the air compressors.
Generation of bacteriophage aerosols in the BioPDO™ manufacturing facility 
is largely driven by failure points in containment systems, including the industry-
standard water-web hypochlorous acid scrubber system for fermentor vent stream 
treatment, as well as the use of open liquid transfer systems, such as trench drains 
that are used for streams originating from steam interlocks on sample systems, 
drains from sample sinks, drains from vapor–liquid separators, and unintended 
leaks from heat exchangers and piping. Efforts to ensure that these streams are 
transferred by closed piping systems to chemical or steam deactivation systems 
is critical for achieving low airborne concentrations of bacteriophage in the 
manufacturing environment. Frequent cleaning of these areas with disinfectants 
has been shown to be critical for limiting dispersion in the manufacturing facility 
 environment [32].
3. Conclusions
As the most abundant biological entity on the planet, bacteriophages play 
an important ecological role in ecosystems and have also been exploited for the 
development of many modern technologies, including gene transfer and treatment 
of bacterial infections [7, 14, 21, 23]. The presence of bacteriophage in an industrial 
fermentation facility can be a serious problem, resulting in reduced product  quality, 
loss in production facility operability, and financial losses to a business. In this 
chapter, we have described basic and applied research efforts around our goal of 
reducing the impact of bacteriophage-related losses in a commercial process for the 
manufacture of 1,3-propanediol. The key to success in these efforts was the devel-
opment of rapid diagnostic methods that were subsequently leveraged by a diverse 
team to quickly diagnose and eliminate sources of bacteriophage in a fast-paced 
manufacturing environment.
Many of the solutions related to operating a manufacturing facility bacterio-
phage-free require participation of a cross-disciplinary team that encompass many 
areas of expertise, including virology, microbiology, microbial ecology, chemical, 
and mechanical engineering. As with any new biomanufacturing process, designers 
utilize a basic set of assumptions that serve in the design and construction of the 
facility. Some of these assumptions are not fully tested in a pilot plant, and the issues 
that arise are often seen for the first time in the commercial fermentation facility. 
In this chapter, we have characterized issues related to the use of 0.2 μm (absolute) 
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sterile filters as the only mechanism for exclusion of bacteriophage from the fer-
mentation process. This issue is especially problematic since these filters were not 
specifically designed for removal of irregular bacteriophage particles with diameters 
(0.075 μm), which is significantly smaller than the stated filter cutoff size.
Our studies indicate that CRISPR/Cas9-mediated resistance to bacteriophage 
DTL in the E. coli PDO production strain is a highly effective strategy for elimi-
nating bacteriophage virulence. The CRISPR spacer customization strategy 
further ensures that spacers are not generated against foreign DNA that that is 
inserted into the production host as part of future host improvement (transfor-
mation) projects. Furthermore, the metabolic burden hypothesis proposed by 
Vale et al. [19] is avoided since we have limited the spacer library to a total of 
seven spacers. The main disadvantage of this approach is that this recombinant 
CRISPR system has a narrow range of bacteriophage specificity, and that there 
is a significant selection pressure for sequence modifications that are not recog-
nized by this existing spacer library. In this regard, there is a difficult balance 
between spacer library size as an assurance of bacteriophage resistance, and 
acceptance of lower 1,3-propanediol productivity due to the metabolic burden 
due to the increase in spacer library size.
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